KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Depreciation and Depletion (2016 - 2022)

TherapeuticsMD filings provide 13 years of Depreciation and Depletion readings, the most recent being $200000.0 for Q4 2022.

  • On a quarterly basis, Depreciation and Depletion rose 200.0% to $200000.0 in Q4 2022 year-over-year; TTM through Sep 2023 was $200000.0, a 33.33% decrease, with the full-year FY2022 number at $600000.0, up 50.0% from a year prior.
  • Depreciation and Depletion hit $200000.0 in Q4 2022 for TherapeuticsMD, roughly flat from $200000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $200000.0 in Q2 2020 to a low of -$200000.0 in Q4 2021.
  • Median Depreciation and Depletion over the past 5 years was $187625.0 (2019), compared with a mean of $124020.6.
  • Biggest five-year swings in Depreciation and Depletion: surged 200.5% in 2020 and later tumbled 200.0% in 2021.
  • TherapeuticsMD's Depreciation and Depletion stood at $59989.0 in 2018, then soared by 193.8% to $176250.0 in 2019, then increased by 13.48% to $200000.0 in 2020, then tumbled by 200.0% to -$200000.0 in 2021, then skyrocketed by 200.0% to $200000.0 in 2022.
  • The last three reported values for Depreciation and Depletion were $200000.0 (Q4 2022), $200000.0 (Q3 2022), and $200000.0 (Q2 2022) per Business Quant data.